{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T03:56:27Z","timestamp":1782014187096,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:00Z","timestamp":1544832000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:00Z","timestamp":1544832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R15DA038295"],"award-info":[{"award-number":["R15DA038295"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00213-018-5145-8","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T17:31:59Z","timestamp":1544895119000},"page":"963-971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats"],"prefix":"10.1007","volume":"236","author":[{"given":"Harmony I.","family":"Risca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-5570","authenticated-orcid":false,"given":"Lisa E.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,15]]},"reference":[{"key":"5145_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","volume":"71","author":"SM Aarde","year":"2013","unstructured":"Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130\u2013140. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.003","journal-title":"Neuropharmacology"},{"issue":"11","key":"5145_CR2","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00213-014-3819-4","volume":"232","author":"SM Aarde","year":"2015","unstructured":"Aarde SM, Huang PK, Dickerson TJ, Taffe MA (2015) Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats. Psychopharmacology 232(11):1867\u20131877. https:\/\/doi.org\/10.1007\/s00213-014-3819-4","journal-title":"Psychopharmacology"},{"key":"5145_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","volume":"166","author":"PH Andersen","year":"1989","unstructured":"Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166:493\u2013504. https:\/\/doi.org\/10.1016\/0014-2999(89)90363-4","journal-title":"Eur J Pharmacol"},{"key":"5145_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/7854_2017_476","volume-title":"Behavioral neurobiology of psychedelic drugs. Current Topics in Behavioral Neurosciences","author":"LE Baker","year":"2017","unstructured":"Baker LE (2017) Hallucinogens in drug discrimination. In: Halberstadt AL, Vollenweider FX, Nichols DE (eds) Behavioral neurobiology of psychedelic drugs. Current Topics in Behavioral Neurosciences, vol 36. Springer, Berlin, Heidelberg, pp 201\u2013219"},{"key":"5145_CR5","doi-asserted-by":"publisher","unstructured":"Baker LE, Broadbent J, Michael EK, Matthews PK, Metosh CA, Saunders RB, West WB, Appel JB (1995) Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Behav Pharmacol. https:\/\/doi.org\/10.1097\/00008877-199504000-00007","DOI":"10.1097\/00008877-199504000-00007"},{"key":"5145_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2012) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38:552. https:\/\/doi.org\/10.1038\/npp.2012.204","journal-title":"Neuropsychopharmacology"},{"key":"5145_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/FBP.0000000000000310","volume":"28","author":"MD Berquist","year":"2017","unstructured":"Berquist MD, Baker LE (2017) Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats. Behav Pharmacol 28:394\u2013400. https:\/\/doi.org\/10.1097\/FBP.0000000000000310","journal-title":"Behav Pharmacol"},{"key":"5145_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/00008877-199210000-00003","volume":"3","author":"J Broadbent","year":"1992","unstructured":"Broadbent J, Appel JB, Michael EK, Ricker JH (1992) Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA). Behav Pharmacol 3:443\u2013454. https:\/\/doi.org\/10.1097\/00008877-199210000-00003","journal-title":"Behav Pharmacol"},{"key":"5145_CR9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0022-3565(25)22199-1","volume":"246","author":"PM Callahan","year":"1988","unstructured":"Callahan PM, Appel JB (1988) Differences in the stimulus properties of 3, 4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. J Pharmacol Exp Ther 246:866\u2013870 http:\/\/jpet.aspetjournals.org\/content\/246\/3\/866","journal-title":"J Pharmacol Exp Ther"},{"key":"5145_CR10","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/bph.12061","volume":"168","author":"KN Cameron","year":"2013","unstructured":"Cameron KN, Kolanos R, Solis E, Glennon RA, De Felice LJ (2013) Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 168:1750\u20131757. https:\/\/doi.org\/10.1111\/bph.12061","journal-title":"Br J Pharmacol"},{"key":"5145_CR11","unstructured":"Centers for Disease Control and Prevention (CDC) (2011) Emergency department visits after use of a drug sold as \u201cbath salts\u201d\u2014Michigan, November 13, 2010\u2014March 31, 2011. Morbidity and mortality weekly report 60, MMWR, pp. 624\u2013627. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6019a6.htm . Accessed 26 Feb 2018"},{"key":"5145_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF02244175","volume":"104","author":"KA Cunningham","year":"1991","unstructured":"Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104:177\u2013180. https:\/\/doi.org\/10.1007\/BF02244175","journal-title":"Psychopharmacology"},{"key":"5145_CR13","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803\u20131815. https:\/\/doi.org\/10.1016\/j.bcp.2013.04.004","journal-title":"Biochem Pharmacol"},{"key":"5145_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/npp.2012.233","volume":"38","author":"WE Fantegrossi","year":"2013","unstructured":"Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused \u2018bath salt\u2019 constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38:563. https:\/\/doi.org\/10.1038\/npp.2012.233","journal-title":"Neuropsychopharmacology"},{"key":"5145_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13181-014-0446-8","volume":"11","author":"Froberg","year":"2015","unstructured":"Froberg, Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, Mckeown NJ, Rosenbaum CD, Young AC, Rusyniak DE, ACMT Toxicology Investigators Consortium (2015) Acute methylenedioxypyrovalerone toxicity. J Med Toxicol 11:185\u2013194. https:\/\/doi.org\/10.1007\/s13181-014-0446-8","journal-title":"J Med Toxicol"},{"key":"5145_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1124\/jpet.115.229500","volume":"356","author":"BM Gannon","year":"2016","unstructured":"Gannon BM, Williamson A, Suzuki M, Rice KC, Fantegrossi WE (2016) Stereoselective effects of abused \u201cbath salt\u201d constituent 3,4-methylenedioxypyrovalerone in mice: drug discrimination, locomotor activity, and thermoregulation. J Pharmacol Exp Ther 356:615\u2013623. https:\/\/doi.org\/10.1124\/jpet.115.229500","journal-title":"J Pharmacol Exp Ther"},{"key":"5145_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/jpet.116.239376","volume":"361","author":"BM Gannon","year":"2017","unstructured":"Gannon BM, Galindo KI, Rice KC, Collins GT (2017) Individual differences in the relative reinforcing effects of 3,4-methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats. J Pharmacol Exp Ther 361:181\u2013189. https:\/\/doi.org\/10.1124\/jpet.116.239376","journal-title":"J Pharmacol Exp Ther"},{"key":"5145_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","volume":"24","author":"MB Gatch","year":"2013","unstructured":"Gatch MB, Taylor CM, Forster MJ (2013) Locomotor stimulant and discriminative stimulus effects of \u2018bath salt\u2019 cathinones. Behav Pharmacol 24:437\u2013447. https:\/\/doi.org\/10.1097\/fbp.0b013e328364166d","journal-title":"Behav Pharmacol"},{"key":"5145_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0014-2999(84)90250-4","volume":"99","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Young R (1984) MDA: an agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine. Eur J Pharmacol 99:249\u2013250. https:\/\/doi.org\/10.1016\/0014-2999(84)90250-4","journal-title":"Eur J Pharmacol"},{"key":"5145_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/9781118023150","volume-title":"Drug discrimination: applications to medicinal chemistry and drug studies","author":"RA Glennon","year":"2011","unstructured":"Glennon RA, Young R (2011) Drug discrimination: applications to medicinal chemistry and drug studies. Wiley, Hoboken"},{"key":"5145_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1037\/1064-1297.8.3.415","volume":"8","author":"AK Goodwin","year":"2000","unstructured":"Goodwin AK, Baker LE (2000) A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (\u00b1)-MDMA in rats. Exp Clin Psychopharmacol 8:415\u2013423. https:\/\/doi.org\/10.1037\/\/1064-1297.8.3.415","journal-title":"Exp Clin Psychopharmacol"},{"key":"5145_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0091-3057(03)00029-7","volume":"74","author":"AK Goodwin","year":"2003","unstructured":"Goodwin AK, Pynnonen DM, Baker LE (2003) Serotonergic\u2013dopaminergic mediation of MDMAs discriminative stimulus effects in a three-choice discrimination. Pharmacol Biochem Behav 74:987\u2013995. https:\/\/doi.org\/10.1016\/s0091-3057(03)00029-7","journal-title":"Pharmacol Biochem Behav"},{"key":"5145_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00213-015-4142-4","volume":"233","author":"EL Harvey","year":"2016","unstructured":"Harvey EL, Baker LE (2016) Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine MDMA mixture. Psychopharmacology 233:673\u2013680. https:\/\/doi.org\/10.1007\/s00213-015-4142-4","journal-title":"Psychopharmacology"},{"key":"5145_CR24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/FBP.0000000000000328","volume":"28","author":"EL Harvey","year":"2017","unstructured":"Harvey EL, Burroughs RL, Baker LE (2017) Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine. Behav Pharmacol 28:586\u2013589. https:\/\/doi.org\/10.1097\/fbp.0000000000000328","journal-title":"Behav Pharmacol"},{"key":"5145_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pbb.2015.07.013","volume":"137","author":"HE King","year":"2015","unstructured":"King HE, Wakeford A, Taylor W et al (2015a) Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences. Pharmacol Biochem Behav 137:16\u201322. https:\/\/doi.org\/10.1016\/j.pbb.2015.07.013","journal-title":"Pharmacol Biochem Behav"},{"key":"5145_CR26","doi-asserted-by":"publisher","unstructured":"King HE, Wetzell B, Rice K, Riley A (2015b) An assessment of MDPV-induced place preference in adult Sprague-Dawley rats. Drug Alcohol Depend. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.07.310","DOI":"10.1016\/j.drugalcdep.2015.07.310"},{"key":"5145_CR27","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1021\/jm960305h","volume":"39","author":"D Matecka","year":"1996","unstructured":"Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FH, Rice KC (1996) Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909). J Med Chem 39:4704\u20134716. https:\/\/doi.org\/10.1021\/jm960305h","journal-title":"J Med Chem"},{"key":"5145_CR28","first-page":"15901","volume-title":"Situation report: synthetic cathinones (bath salts): an emerging domestic threat","author":"National Drug Intelligence Center","year":"2011","unstructured":"National Drug Intelligence Center (2011) Situation report: synthetic cathinones (bath salts): an emerging domestic threat. National Drug Intelligence Center, Johnstown, pp 15901\u201311622 http:\/\/www.justice.gov\/archive\/ndic\/pubs44\/44571\/44571p.pdf . Accessed 28 May 2018"},{"key":"5145_CR29","unstructured":"National Research Council of the National Academies (2011) Guide for the Care and use of laboratory animals, 8th ed. Washington D.C., The National Academies Press"},{"key":"5145_CR30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.amjmed.2012.02.019","volume":"125","author":"EA Ross","year":"2012","unstructured":"Ross EA, Reisfield GM, Watson MC et al (2012) Psychoactive \u201cbath salts\u201d intoxication with methylenedioxypyrovalerone. Am J Med 125:854\u2013858. https:\/\/doi.org\/10.1016\/j.amjmed.2012.02.019","journal-title":"Am J Med"},{"key":"5145_CR31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","volume":"233","author":"CW Schindler","year":"2016","unstructured":"Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD, Baumann MH (2016) Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233:1981\u20131990. https:\/\/doi.org\/10.1007\/s00213-015-4057-0","journal-title":"Psychopharmacology"},{"key":"5145_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"L Simmler","year":"2013","unstructured":"Simmler L, Buser T, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458\u2013470. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02145.x","journal-title":"Br J Pharmacol"},{"key":"5145_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/15563650.2011.590812","volume":"49","author":"HA Spiller","year":"2011","unstructured":"Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States. Clin Toxicol 49:499\u2013505. https:\/\/doi.org\/10.3109\/15563650.2011.590812","journal-title":"Clin Toxicol"},{"key":"5145_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/FBP.0b013e328349ab37","volume":"22","author":"IP Stolerman","year":"2011","unstructured":"Stolerman IP, Childs E, Ford MM, Grant KA (2011) Role of training dose in drug discrimination: a review. Behav Pharmacol 22:415\u2013429. https:\/\/doi.org\/10.1097\/FBP.0b013e328349ab37","journal-title":"Behav Pharmacol"},{"key":"5145_CR35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0278-5846(00)00180-9","volume":"25","author":"SR Tella","year":"2001","unstructured":"Tella SR, Goldberg SR (2001) Subtle differences in the discriminative stimulus effects of cocaine and GBR-12909. Prog Neuro-Psychopharmacol Biol Psychiatry 25:639\u2013656. https:\/\/doi.org\/10.1016\/S0278-5846(00)00180-9","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5145_CR36","volume-title":"United Nations Office on Drugs and Crime: World Drug Report 2015","author":"UNODC","year":"2015","unstructured":"UNODC (2015) United Nations Office on Drugs and Crime: World Drug Report 2015. United Nations publication, New York http:\/\/www.undoc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf . Accessed 29 June 2018"},{"key":"5145_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","volume":"88","author":"MJ Valente","year":"2014","unstructured":"Valente MJ, De Pinho PG, de Lourdes Bastos M, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88:15\u201345. https:\/\/doi.org\/10.1007\/s00204-013-1163-9","journal-title":"Arch Toxicol"},{"key":"5145_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","volume":"19","author":"LR Watterson","year":"2014","unstructured":"Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, Marusich JA, Wegner S, Olive MF (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19:165\u2013174. https:\/\/doi.org\/10.1111\/j.1369-1600.2012.00474.x","journal-title":"Addict Biol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-5145-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:35:09Z","timestamp":1775313309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-5145-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,15]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["5145"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-5145-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,15]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were reviewed and approved by the Western Michigan University Institutional Animal Care and Use Committee, and were in accordance with the guidelines of the Guide for the Care and Use of Laboratory Animals (National Research Council of the National Academies\n                      \n                      ).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}